The value of serum antimicrosomal antibody testing in screening for symptomatic postpartum thyroid dysfunction

Clifford C. Hayslip, Henry G. Fein, Vincent M. O'Donnell, Debra S. Friedman, Thomas A. Klein, Robert C. Smallridge

Research output: Contribution to journalArticle

Abstract

We investigated the value of a screening program for postpartum thyroiditis in a heterogeneous American population and used serum antithyroid antibodies to identify postpartum women at risk. Blood was drawn from 1034 consecutive women on their second postpartum day and tested for antimicrosomal and antithyroglobulin antibodies by hemagglutination. Seventy-two women (7.0%) were seropositive for antimicrosomal antibodies, but only seven (0.7%) had antithyroglobulin antibodies. There was a significant difference in the racial prevalence of antimicrosomal antibodies, with seropositivity in 52 of 588 white women (8.8%) versus nine of 367 black women (2.5%; p <0.001). Thirty-four of 51 (67%) antimicrosomal seropositive women followed at least 6 months post partum developed biochemical thyroid dysfunction and 20 of these patients required treatment for hypothyroidism. The mean (±SEM) serum thyroxine and thyrotropin levels in these patients before treatment were 3.0 ± 0.3 μg/dl (normal 6.1 to 12.3 μg/dl) and 77 ± 17 mU/L (normal 0.3 to 4.0 mU/L), respectively. Psychologic interviews revealed a significant increase in impaired concentration, carelessness, depression, and total complaints when patients with postpartum hypothyroidism were compared with postpartum euthyroid women. Medical evidence now suggests that postpartum thyroiditis is a common event and causes significant symptoms in women who develop hypothyroidism. Therefore, we propose that serum antimicrosomal antibody testing of postpartum women provides a feasible cost-effective screening method of identifying women likely to suffer from this disease.

Original languageEnglish (US)
Pages (from-to)203-209
Number of pages7
JournalAmerican Journal of Obstetrics and Gynecology
Volume159
Issue number1
DOIs
StatePublished - 1988
Externally publishedYes

Fingerprint

Postpartum Period
Thyroid Gland
Antibodies
Serum
Postpartum Thyroiditis
Hypothyroidism
Psychological Interviews
Hemagglutination
Thyrotropin
Thyroxine
Depression
Costs and Cost Analysis
Therapeutics
Population

Keywords

  • Postpartum thyroid dysfunction
  • racial differences
  • thyroid antibodies

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

The value of serum antimicrosomal antibody testing in screening for symptomatic postpartum thyroid dysfunction. / Hayslip, Clifford C.; Fein, Henry G.; O'Donnell, Vincent M.; Friedman, Debra S.; Klein, Thomas A.; Smallridge, Robert C.

In: American Journal of Obstetrics and Gynecology, Vol. 159, No. 1, 1988, p. 203-209.

Research output: Contribution to journalArticle

Hayslip, Clifford C. ; Fein, Henry G. ; O'Donnell, Vincent M. ; Friedman, Debra S. ; Klein, Thomas A. ; Smallridge, Robert C. / The value of serum antimicrosomal antibody testing in screening for symptomatic postpartum thyroid dysfunction. In: American Journal of Obstetrics and Gynecology. 1988 ; Vol. 159, No. 1. pp. 203-209.
@article{52a9b2ce383743888fa3b591f668898b,
title = "The value of serum antimicrosomal antibody testing in screening for symptomatic postpartum thyroid dysfunction",
abstract = "We investigated the value of a screening program for postpartum thyroiditis in a heterogeneous American population and used serum antithyroid antibodies to identify postpartum women at risk. Blood was drawn from 1034 consecutive women on their second postpartum day and tested for antimicrosomal and antithyroglobulin antibodies by hemagglutination. Seventy-two women (7.0{\%}) were seropositive for antimicrosomal antibodies, but only seven (0.7{\%}) had antithyroglobulin antibodies. There was a significant difference in the racial prevalence of antimicrosomal antibodies, with seropositivity in 52 of 588 white women (8.8{\%}) versus nine of 367 black women (2.5{\%}; p <0.001). Thirty-four of 51 (67{\%}) antimicrosomal seropositive women followed at least 6 months post partum developed biochemical thyroid dysfunction and 20 of these patients required treatment for hypothyroidism. The mean (±SEM) serum thyroxine and thyrotropin levels in these patients before treatment were 3.0 ± 0.3 μg/dl (normal 6.1 to 12.3 μg/dl) and 77 ± 17 mU/L (normal 0.3 to 4.0 mU/L), respectively. Psychologic interviews revealed a significant increase in impaired concentration, carelessness, depression, and total complaints when patients with postpartum hypothyroidism were compared with postpartum euthyroid women. Medical evidence now suggests that postpartum thyroiditis is a common event and causes significant symptoms in women who develop hypothyroidism. Therefore, we propose that serum antimicrosomal antibody testing of postpartum women provides a feasible cost-effective screening method of identifying women likely to suffer from this disease.",
keywords = "Postpartum thyroid dysfunction, racial differences, thyroid antibodies",
author = "Hayslip, {Clifford C.} and Fein, {Henry G.} and O'Donnell, {Vincent M.} and Friedman, {Debra S.} and Klein, {Thomas A.} and Smallridge, {Robert C.}",
year = "1988",
doi = "10.1016/0002-9378(88)90522-4",
language = "English (US)",
volume = "159",
pages = "203--209",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - The value of serum antimicrosomal antibody testing in screening for symptomatic postpartum thyroid dysfunction

AU - Hayslip, Clifford C.

AU - Fein, Henry G.

AU - O'Donnell, Vincent M.

AU - Friedman, Debra S.

AU - Klein, Thomas A.

AU - Smallridge, Robert C.

PY - 1988

Y1 - 1988

N2 - We investigated the value of a screening program for postpartum thyroiditis in a heterogeneous American population and used serum antithyroid antibodies to identify postpartum women at risk. Blood was drawn from 1034 consecutive women on their second postpartum day and tested for antimicrosomal and antithyroglobulin antibodies by hemagglutination. Seventy-two women (7.0%) were seropositive for antimicrosomal antibodies, but only seven (0.7%) had antithyroglobulin antibodies. There was a significant difference in the racial prevalence of antimicrosomal antibodies, with seropositivity in 52 of 588 white women (8.8%) versus nine of 367 black women (2.5%; p <0.001). Thirty-four of 51 (67%) antimicrosomal seropositive women followed at least 6 months post partum developed biochemical thyroid dysfunction and 20 of these patients required treatment for hypothyroidism. The mean (±SEM) serum thyroxine and thyrotropin levels in these patients before treatment were 3.0 ± 0.3 μg/dl (normal 6.1 to 12.3 μg/dl) and 77 ± 17 mU/L (normal 0.3 to 4.0 mU/L), respectively. Psychologic interviews revealed a significant increase in impaired concentration, carelessness, depression, and total complaints when patients with postpartum hypothyroidism were compared with postpartum euthyroid women. Medical evidence now suggests that postpartum thyroiditis is a common event and causes significant symptoms in women who develop hypothyroidism. Therefore, we propose that serum antimicrosomal antibody testing of postpartum women provides a feasible cost-effective screening method of identifying women likely to suffer from this disease.

AB - We investigated the value of a screening program for postpartum thyroiditis in a heterogeneous American population and used serum antithyroid antibodies to identify postpartum women at risk. Blood was drawn from 1034 consecutive women on their second postpartum day and tested for antimicrosomal and antithyroglobulin antibodies by hemagglutination. Seventy-two women (7.0%) were seropositive for antimicrosomal antibodies, but only seven (0.7%) had antithyroglobulin antibodies. There was a significant difference in the racial prevalence of antimicrosomal antibodies, with seropositivity in 52 of 588 white women (8.8%) versus nine of 367 black women (2.5%; p <0.001). Thirty-four of 51 (67%) antimicrosomal seropositive women followed at least 6 months post partum developed biochemical thyroid dysfunction and 20 of these patients required treatment for hypothyroidism. The mean (±SEM) serum thyroxine and thyrotropin levels in these patients before treatment were 3.0 ± 0.3 μg/dl (normal 6.1 to 12.3 μg/dl) and 77 ± 17 mU/L (normal 0.3 to 4.0 mU/L), respectively. Psychologic interviews revealed a significant increase in impaired concentration, carelessness, depression, and total complaints when patients with postpartum hypothyroidism were compared with postpartum euthyroid women. Medical evidence now suggests that postpartum thyroiditis is a common event and causes significant symptoms in women who develop hypothyroidism. Therefore, we propose that serum antimicrosomal antibody testing of postpartum women provides a feasible cost-effective screening method of identifying women likely to suffer from this disease.

KW - Postpartum thyroid dysfunction

KW - racial differences

KW - thyroid antibodies

UR - http://www.scopus.com/inward/record.url?scp=0023727114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023727114&partnerID=8YFLogxK

U2 - 10.1016/0002-9378(88)90522-4

DO - 10.1016/0002-9378(88)90522-4

M3 - Article

C2 - 3394739

AN - SCOPUS:0023727114

VL - 159

SP - 203

EP - 209

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 1

ER -